R13	PredicateNominative Attribute:T139 Head:T105
R14	PredicateNominative Attribute:T140 Head:T77
R15	PredicateNominative Attribute:T143 Head:T78
R16	Anaphora Anaphor:T142 Antecedent:T77
R17	Anaphora Anaphor:T145 Antecedent:T78
R18	Anaphora Anaphor:T151 Antecedent:T107
R19	Anaphora Anaphor:T156 Antecedent:T43
R20	Anaphora Anaphor:T175 Antecedent:T82
R21	Anaphora Anaphor:T242 Antecedent:T99
R22	Anaphora Anaphor:T244 Antecedent:T242
T2	Drug 1314 1323	aliskiren
T3	Drug 1329 1335	AVAPRO
T7	Drug_Class 6517 6557	cytochrome CYP 2C9 substrates/inhibitors
T8	Drug 6558 6570	sulphenazole
T9	Drug 6572 6583	tolbutamide
T10	Drug 6588 6598	nifedipine
T11	Drug 6479 6489	irbesartan
T12	Drug_Class 7267 7294	potassium-sparing diuretics
T13	Drug_Class 7296 7317	potassium supplements
T14	Substance 7322 7359	salt substitutes containing potassium
T19	Drug 11657 11676	Hydrochlorothiazide
T21	Drug 11643 11649	AVAPRO
T22	Drug_Class 7542 7548	NSAIDs
T23	Drug_Class 7560 7586	selective COX-2 inhibitors
T24	Drug_Class 7593 7628	angiotensin II receptor antagonists
T25	Drug 7640 7650	irbesartan
T29	Drug 7835 7845	irbesartan
T30	Drug_Class 7850 7855	NSAID
T32	Drug_Class 7896 7931	angiotensin II receptor antagonists
T33	Drug 7943 7953	irbesartan
T34	Drug_Class 7976 7982	NSAIDs
T35	Drug_Class 7993 8019	selective COX-2 inhibitors
T36	Drug_Class 8051 8080	angiotensin-receptor blockers
T37	Drug_Class 8082 8096	ACE inhibitors
T38	Drug 8101 8110	aliskiren
T44	Drug 8343 8349	AVAPRO
T45	Drug_Class 8360 8386	agents that affect the RAS
T47	Drug 8408 8417	aliskiren
T48	Drug 8423 8429	AVAPRO
T51	Drug 8470 8479	aliskiren
T52	Drug 8485 8491	AVAPRO
T54	Drug_Class 2144 2188	drugs affecting the renin-angiotensin system
T55	Drug_Class 2428 2472	drugs affecting the renin-angiotensin system
T56	Drug_Class 5680 5694	ACE inhibitors
T57	Drug_Class 2200 2223	antihypertensive agents
T58	Drug_Class 11345 11368	antihypertensive agents
T59	Drug_Class 4464 4488	antihypertensive therapy
T60	Drug 6370 6377	digoxin
T61	Drug 6990 6997	digoxin
T62	Drug 7128 7135	digoxin
T63	Drug_Class 4625 4634	diuretics
T64	Drug_Class 12408 12417	diuretics
T65	Drug_Class 7467 7475	diuretic
T66	Drug_Class 11581 11589	diuretic
T67	Drug 6349 6368	hydrochlorothiazide
T68	Drug 6966 6985	hydrochlorothiazide
T69	Drug 7227 7246	hydrochlorothiazide
T70	Drug 787 794	alcohol
T71	Drug 6379 6387	warfarin
T72	Drug 6699 6707	warfarin
T73	Drug 6956 6964	warfarin
T74	Drug 7077 7085	warfarin
T75	Drug 45 55	irbesartan
T76	Drug 322 332	irbesartan
T77	Drug 390 400	Irbesartan
T78	Drug 572 582	Irbesartan
T79	Drug 753 763	Irbesartan
T80	Drug 957 967	irbesartan
T81	Drug 3133 3143	irbesartan
T82	Drug 3670 3680	irbesartan
T83	Drug 3874 3884	irbesartan
T84	Drug 4129 4139	Irbesartan
T85	Drug 4331 4341	irbesartan
T86	Drug 6661 6671	irbesartan
T87	Drug 6999 7009	irbesartan
T88	Drug 7161 7171	irbesartan
T89	Drug 8592 8602	irbesartan
T90	Drug 8822 8832	irbesartan
T91	Drug 8999 9009	irbesartan
T92	Drug 9224 9234	irbesartan
T93	Drug 9304 9314	Irbesartan
T94	Drug 9467 9477	Irbesartan
T95	Drug 9620 9630	Irbesartan
T96	Drug 9779 9789	irbesartan
T97	Drug 9989 9999	irbesartan
T98	Drug 10031 10041	irbesartan
T99	Drug 10064 10074	irbesartan
T100	Drug 10594 10604	Irbesartan
T101	Drug 10864 10874	irbesartan
T102	Drug 11435 11445	irbesartan
T103	Drug 26 32	Avapro
T104	Drug 123 129	AVAPRO
T105	Drug 314 320	AVAPRO
T106	Drug 854 860	AVAPRO
T107	Drug 1199 1205	AVAPRO
T108	Drug 1855 1861	AVAPRO
T109	Drug 2679 2685	AVAPRO
T110	Drug 3010 3016	AVAPRO
T111	Drug 4732 4738	AVAPRO
T112	Drug 5620 5626	AVAPRO
T113	Drug 5847 5853	AVAPRO
T114	Drug 6051 6057	AVAPRO
T115	Drug 10756 10762	AVAPRO
T116	Drug 10856 10862	AVAPRO
T117	Drug 11307 11313	AVAPRO
T118	Drug 11427 11433	AVAPRO
T119	Drug 12176 12182	AVAPRO
T120	Drug 12279 12285	AVAPRO
T121	Drug 6393 6403	nifedipine
T122	Drug 7213 7223	nifedipine
T123	Substance 7391 7400	potassium
T124	Drug_Class 2077 2093	antihypertensive
T125	Drug_Class 7869 7885	antihypertensive
T20	Substance 999 1018	lactose monohydrate
T26	Substance 1020 1046	microcrystalline cellulose
T27	Substance 1048 1069	croscarmellose sodium
T28	Substance 1071 1083	hypromellose
T31	Substance 1085 1100	silicon dioxide
T39	Substance 1102 1120	magnesium stearate
T40	Substance 1122 1138	titanium dioxide
T41	Substance 1144 1168	polyethylene glycol 3000
T43	Drug_Class 1427 1473	drugs that act on the renin-angiotensin system
T264	SPAN 6177 6188	pregnancies
T134	ZeroArticleNP 0 10	Drug Label
T135	ZeroArticleNP 15 32	drug brand Avapro
T136	DefiniteNP 180 208	the renin-angiotensin system
T137	DefiniteNP 239 259	the developing fetus
T138	ZeroArticleNP 153 158	Drugs
T139	IndefiniteNP 337 388	an angiotensin II receptor (AT1 subtype) antagonist
T140	IndefiniteNP 404 426	a non-peptide compound
T141	IndefiniteNP 452 463	a 2-butyl-3
T142	PossessivePronoun 536 557	Its empirical formula
T143	IndefiniteNP 586 625	a white to off-white crystalline powder
T144	IndefiniteNP 631 649	a molecular weight
T145	PersonalPronoun 660 662	It
T146	IndefiniteNP 666 685	a nonpolar compound
T147	IndefiniteNP 691 714	a partition coefficient
T148	ZeroArticleNP 901 917	unscored tablets
T149	ZeroArticleNP 969 989	Inactive ingredients
T150	IndefiniteNP 1263 1276	any component
T151	DemonstrativeNP 1280 1292	this product
T152	ZeroArticleNP 1380 1397	Drug Interactions
T153	DefiniteNP 1481 1512	the second and third trimesters
T154	DefiniteNP 1956 1987	the second and third trimesters
T155	DemonstrativeNP 1883 1905	These adverse outcomes
T156	DemonstrativeNP 1941 1952	these drugs
T157	DefiniteNP 2101 2120	the first trimester
T158	IndefiniteNP 2194 2223	other antihypertensive agents
T159	DefiniteNP 2354 2370	the unusual case
T160	DefiniteNP 2507 2517	the mother
T161	DefiniteNP 2521 2539	the potential risk
T162	DefiniteNP 2543 2552	the fetus
T163	IndefiniteNP 2477 2497	a particular patient
T164	ZeroArticleNP 2415 2422	therapy
T165	DefiniteNP 2603 2633	the intra-amniotic environment
T166	PersonalPronoun 2694 2696	it
T167	DefiniteNP 2726 2736	the mother
T168	DefiniteNP 2781 2789	the week
T169	DefiniteNP 2902 2911	the fetus
T170	DefiniteNP 3411 3422	the maximum
T171	IndefiniteNP 3467 3492	a body surface area basis
T172	DefiniteNP 3576 3584	the MRHD
T173	IndefiniteNP 3588 3613	a body surface area basis
T174	PersonalPronoun 3772 3776	they
T175	DefiniteNP 3823 3831	the drug
T176	DemonstrativeNP 3619 3634	these anomalies
T177	DefiniteNP 4001 4009	the MRHD
T178	IndefiniteNP 4013 4038	a body surface area basis
T179	IndefiniteNP 4044 4061	a slight increase
T180	IndefiniteNP 4087 4111	a corresponding decrease
T181	DemonstrativeNP 3974 3983	this dose
T182	DefiniteNP 4159 4180	the placental barrier
T183	DefiniteNP 4231 4255	the rat and rabbit fetus
T184	ZeroArticleNP 4464 4488	antihypertensive therapy
T185	ZeroArticleNP 4625 4634	diuretics
T186	IndefiniteNP 4743 4762	a low starting dose
T187	DemonstrativeNP 4663 4684	Such volume depletion
T188	DefiniteNP 4835 4846	the patient
T189	DefiniteNP 4867 4886	the supine position
T190	IndefiniteNP 4912 4935	an intravenous infusion
T191	DefiniteNP 5090 5108	the blood pressure
T192	IndefiniteNP 4954 4986	A transient hypotensive response
T193	IndefiniteNP 4994 5012	a contraindication
T194	DefiniteNP 5178 5218	the renin-angiotensin-aldosterone system
T195	IndefiniteNP 5150 5163	a consequence
T196	DefiniteNP 5340 5352	the activity
T197	DefiniteNP 5356 5396	the renin-angiotensin-aldosterone system
T198	ZeroArticleNP 5465 5505	angiotensin-converting-enzyme inhibitors
T199	ZeroArticleNP 5680 5694	ACE inhibitors
T200	IndefiniteNP 5922 5938	a similar effect
T201	DefiniteNP 6019 6035	the consequences
T202	PossessivePronoun 6192 6208	their physicians
T203	DefiniteNP 6453 6466	the formation
T204	DefiniteNP 6507 6570	the known cytochrome CYP 2C9 substrates/inhibitors sulphenazole
T205	DefiniteNP 6629 6645	the consequences
T206	DefiniteNP 6675 6695	the pharmacodynamics
T207	ZeroArticleNP 6787 6792	drugs
T208	ZeroArticleNP 6828 6854	cytochrome P450 isoenzymes
T209	DefiniteNP 7053 7073	the pharmacodynamics
T210	DefiniteNP 7137 7157	The pharmacokinetics
T211	ZeroArticleNP 7267 7294	potassium-sparing diuretics
T212	ZeroArticleNP 7322 7359	salt substitutes containing potassium
T213	ZeroArticleNP 7467 7483	diuretic therapy
T214	ZeroArticleNP 7560 7586	selective COX-2 inhibitors
T215	ZeroArticleNP 7593 7628	angiotensin II receptor antagonists
T216	DemonstrativeNP 7739 7752	These effects
T217	ZeroArticleNP 7856 7863	therapy
T218	DefiniteNP 7865 7892	The antihypertensive effect
T219	ZeroArticleNP 7896 7931	angiotensin II receptor antagonists
T220	ZeroArticleNP 7993 8019	selective COX-2 inhibitors
T221	DefiniteNP 8038 8045	the RAS
T222	ZeroArticleNP 8051 8080	angiotensin-receptor blockers
T223	ZeroArticleNP 8082 8096	ACE inhibitors
T224	ZeroArticleNP 8250 8261	monotherapy
T225	IndefiniteNP 8354 8386	other agents that affect the RAS
T226	DefiniteNP 8904 8933	the average systemic exposure
T227	DefiniteNP 8954 8965	the maximum
T228	DefiniteNP 9150 9157	the MRD
T229	IndefiniteNP 8790 8818	an average systemic exposure
T230	IndefiniteNP 9078 9106	an average systemic exposure
T231	DefiniteNP 9270 9288	the human exposure
T232	IndefiniteNP 9209 9220	an exposure
T233	IndefiniteNP 9336 9363	a battery of in vitro tests
T234	DefiniteNP 9729 9745	the highest dose
T235	DefiniteNP 9870 9898	the maximum recommended dose
T236	IndefiniteNP 9756 9775	a systemic exposure
T237	PersonalPronoun 9965 9967	It
T238	DefiniteNP 10111 10119	the milk
T239	IndefiniteNP 10045 10060	some metabolite
T240	DefiniteNP 10150 10163	the potential
T241	DefiniteNP 10187 10205	the nursing infant
T242	DefiniteNP 10279 10287	the drug
T243	DefiniteNP 10309 10323	the importance
T244	DefiniteNP 10327 10335	the drug
T245	DefiniteNP 10339 10349	the mother
T246	IndefiniteNP 10207 10217	a decision
T247	IndefiniteNP 10510 10517	a means
T248	IndefiniteNP 10609 10616	a study
T249	IndefiniteNP 10620 10626	a dose
T250	IndefiniteNP 11137 11159	some older individuals
T251	DemonstrativeNP 11073 11087	these subjects
T252	IndefiniteNP 11339 11368	other antihypertensive agents
T253	DefiniteNP 11395 11423	The recommended initial dose
T254	IndefiniteNP 11565 11575	A low dose
T255	IndefiniteNP 11579 11589	a diuretic
T256	IndefiniteNP 11700 11718	an additive effect
T257	DefiniteNP 11802 11818	the maximum dose
T258	IndefiniteNP 11887 11900	a higher dose
T259	DefiniteNP 12054 12093	The recommended target maintenance dose
T260	DefiniteNP 12137 12157	the clinical effects
T261	IndefiniteNP 12255 12275	A lower initial dose
T262	ZeroArticleNP 12363 12367	salt
T263	ZeroArticleNP 12408 12417	diuretics
